MY129619A - A formulation of dihydroartemisinin for the control of the wide spectrum of malaria and a process for preparing the same. - Google Patents

A formulation of dihydroartemisinin for the control of the wide spectrum of malaria and a process for preparing the same.

Info

Publication number
MY129619A
MY129619A MYPI99001158A MYPI9901158A MY129619A MY 129619 A MY129619 A MY 129619A MY PI99001158 A MYPI99001158 A MY PI99001158A MY PI9901158 A MYPI9901158 A MY PI9901158A MY 129619 A MY129619 A MY 129619A
Authority
MY
Malaysia
Prior art keywords
dihydroartemisinin
control
wide spectrum
malaria
formulation
Prior art date
Application number
MYPI99001158A
Other languages
English (en)
Inventor
Dharam Chandra Jain
Rajendra Singh Bhakuni
Ram Prakash Sharma
Sushil Kumar
Guru Prakash Dutta
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of MY129619A publication Critical patent/MY129619A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI99001158A 1999-02-12 1999-03-26 A formulation of dihydroartemisinin for the control of the wide spectrum of malaria and a process for preparing the same. MY129619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN236DE1999 IN191696B (en]) 1999-02-12 1999-02-12

Publications (1)

Publication Number Publication Date
MY129619A true MY129619A (en) 2007-04-30

Family

ID=11088855

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99001158A MY129619A (en) 1999-02-12 1999-03-26 A formulation of dihydroartemisinin for the control of the wide spectrum of malaria and a process for preparing the same.

Country Status (9)

Country Link
US (2) US6214864B1 (en])
EP (1) EP1034794B1 (en])
JP (1) JP3686281B2 (en])
CN (1) CN1197568C (en])
AU (1) AU763680B2 (en])
DE (1) DE69936186T2 (en])
IN (1) IN191696B (en])
MY (1) MY129619A (en])
ZA (1) ZA992354B (en])

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191696B (en]) * 1999-02-12 2003-12-20 Council Scient Ind Res
WO2001074353A1 (en) * 2000-03-31 2001-10-11 Council Of Scientific And Industrial Research A synergistic anti-malarial formulation
CA2488347A1 (en) * 2002-06-06 2003-12-18 University Of Washington Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
ATE536887T1 (de) * 2002-06-06 2011-12-15 Univ Washington Kovalente konjugate zwischen mit artemisinin verwandten endoperoxiden und eisentragenden proteinen und anwendungsverfahren
CN1814601A (zh) * 2005-02-04 2006-08-09 中国科学院上海药物研究所 具有免疫抑制作用的青蒿素衍生物及药物组合物
CN101421275A (zh) * 2006-03-10 2009-04-29 科学与工业研究委员会 青蒿素一锅转变成蒿酸的方法
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
CN106265481B (zh) * 2016-08-31 2020-06-19 昆药集团股份有限公司 一种蒿甲醚栓剂及其制备方法
CN113552274B (zh) * 2021-07-23 2022-11-29 重庆市中药研究院 一种青蒿素副产物高效液相指纹图谱的建立及含量测定方法
CN114617842A (zh) * 2022-01-05 2022-06-14 沈阳农业大学 一种双氢青蒿素-羧甲基纤维素钠溶液的制备方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (en]) * 1987-05-08 1990-03-24 Hoechst India
US4816478A (en) * 1987-08-24 1989-03-28 Thornfeldt Carl R Treatment of acquired immunodeficiency syndrome
CN1041595A (zh) * 1988-10-04 1990-04-25 赫彻斯特股份公司 新蒿属素衍生物，其制法及其作为抗原虫剂的应用，
US5225427A (en) * 1988-10-04 1993-07-06 Hoechst Aktiengesellschaft 10-substituted ether derivatives of dihydroartemisinin, process for their preparation and their use as antiprotozoal agents
TW198722B (en]) * 1990-05-07 1993-01-21 Hoechst Ag
US5486535A (en) * 1990-06-26 1996-01-23 Regents Of The University Of Colorado Method for treating toxoplasmosis
CN1058717A (zh) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 抗疟新药—复方蒿甲醚及其制备方法
JPH09512794A (ja) * 1994-04-07 1997-12-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー マラリアの治療用のハロファントリン遊離塩基および組成物
GB9622427D0 (en) * 1996-10-28 1997-01-08 Pharma Mar Sa Antimalarial drugs
IN188174B (en]) * 1997-03-17 2002-08-31 Council Scient Ind Res
IN191696B (en]) * 1999-02-12 2003-12-20 Council Scient Ind Res

Also Published As

Publication number Publication date
JP2000239165A (ja) 2000-09-05
IN191696B (en]) 2003-12-20
CN1262927A (zh) 2000-08-16
US6362219B1 (en) 2002-03-26
AU2250799A (en) 2000-08-17
CN1197568C (zh) 2005-04-20
ZA992354B (en) 2000-10-10
US6214864B1 (en) 2001-04-10
EP1034794B1 (en) 2007-05-30
JP3686281B2 (ja) 2005-08-24
DE69936186T2 (de) 2008-01-24
AU763680B2 (en) 2003-07-31
DE69936186D1 (de) 2007-07-12
EP1034794A1 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
WO2002012166A3 (en) Triamine derivative melanocortin receptor ligands and methods of using same
EP1399414A4 (en) SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA
EP1129693A3 (en) Composition for inhibiting body odor and uses thereof
AU2002210952A1 (en) Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist
WO2003053336A3 (en) Methods for the treatment of peripheral neural and vascular ailments
AU2002339378A1 (en) Compartmentalized dosage form
BG105967A (en) C(7) ester substituted taxanes and their use as antitumor agents
AU3652102A (en) Compounds and their uses
WO2005021497A3 (en) Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
MY129619A (en) A formulation of dihydroartemisinin for the control of the wide spectrum of malaria and a process for preparing the same.
WO2000078296A3 (en) Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
AU2002211050A1 (en) Streptomyces kasugaensis inhibiting the fungal pathogens of plant
WO2002076376A3 (en) A stable pharmaceutical composition of pravastatin
AU2002358856A1 (en) Novel artemisinine derivatives, and uses thereof for treating malaria
AU2003201163A1 (en) Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol
AU2001295979A1 (en) Medicinal compositions, dose and method for treating malaria
WO2002080978A3 (en) Pharmaceutical compositions comprising ascomycin
AU6331500A (en) Method for the production of juice from fruits such as pomegranates
EP1335922A4 (en) NOVEL 4'-DEMETHYL-4'-O-SUBSTITUE-1-DEOXYPODOPHYLLOTOXIN DERIVATIVE, GEOMETRIC ISOMER THEREOF, PROCESS FOR PREPARING THE SAME, AND ANTI-CANCER COMPOSITION COMPRISING SAID DERIVATIVE
WO2002026324A3 (en) Tocol-based compositions containing amiodarone
AU2001289506A1 (en) Pharmaceutical composition of dihydroartemisinin for treating malaria
AU4920200A (en) Compositions for the preserving treatment of feeds